Hypertension: which drugs are used in France?
Hypertension drugs are used in France? Iѕ thе medical tеrm fоr a соndіtіоn іn which thе arterial blооd рrеѕѕurе is соnѕіѕtеntlу аbоvе thе nоrmаl rаngе. A blооd pressure rеаdіng соnѕіѕtѕ оf twо numbеrѕ. Thе numbеr at thе tор rерrеѕеntѕ ѕуѕtоlіс рrеѕѕurе. This is thе amount оf pressure that thе hеаrt gеnеrаtеѕ whеn рumріng blооd out thrоugh the arteries. The numbеr bеlоw represents dіаѕtоlіс pressure. This is thе amount оf рrеѕѕurе іn thе аrtеrіеѕ whеn thе hеаrt іѕ аt rest, іn between bеаtѕ. Whеn thе rеаdіng is above thе 140 (ѕуѕtоlіс)/90 (diastolic) rаngе, іt dеnоtеѕ hуреrtеnѕіоn.
Hypertension drugs ? In metropolitan France, 31.2% of people aged over 35 are treated with drugs for hypertension in 2010, reports the French Committee for the Fight against High Blood Pressure (CFLHTA). What are these drugs?
The study, led by CFLHTA and KANTAR-Health in May-June 2010, was done with 1,169 hypertensive patients treated with drugs and living in France.
Treatment of hypertension is obtained with one drug for 62% of those treated. However 25% of prescriptions contain a drug that contains two pharmacological ingredients.
Antagonists of angiotensin receptor (ARA2) are most often prescribed when a drug is used alone (41%). These drugs block the action of angiotensin II, a hormone produced by the kidney which has an important role in regulating blood pressure. Its inhibition causes a decrease in blood pressure.
Read More Article :
Diuretics are often used in combination with either ARA2 (16%) or with an inhibitor of angiotensin converting enzyme (ACE)(4.5%). Diuretics help eliminate water and salt through the kidneys and decrease the volume of fluid flowing through the arteries, lowering the pressure on their wall. ACE inhibitors block the production of angiotensin II.
Beta-blockers are used in isolation in 15.9% of those treated. These drugs cause a slowing of heart rate and decreased force of contraction of the heart.
The ARA2 and ACE inhibitors are drugs newer than diuretics and beta blockers.
In people treated with one drug, it is observed over the period from 2006 to 2010, an increase in the number of people treated with an ACE inhibitor and a decrease in those treated by ARA2. These changes could be the result of strong incentives made by the Caisse Nationale d’Assurance Maladie to doctors to promote generic prescribing of antihypertensive drugs, says CFLHTA.